Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAFV600E: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment

Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAF^V600E: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment

Front Endocrinol (Lausanne). 2020 Oct 9:11:596223. doi: 10.3389/fendo.2020.596223. eCollection 2020.

¹ Human Thyroid Cancers Preclinical and Translational Research Laboratory, Division of Cancer Biology and Angiogenesis, Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, United States.
² Endocrine Service, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
³ Division of Cancer Biology and Angiogenesis, Department of Pathology, Harvard Medical School, Center for Vascular Biology Research (CVBR), Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, United States.

[This corrects the article DOI: 10.3389/fendo.2013.00189.].

Keywords: BRAFV600E; TSP-1; extracellular matrix; integrins; microenvironment; thyroid cancer.